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Abstract Mast cells play a major role in the initiation of in-
£ammation and allergic reactions. As cell numbers are tightly
controlled by the interplay of factors a¡ecting cell proliferation,
development, and death the regulation of mast cell number may
be important. Melanocyte-stimulating hormone inhibits most
forms of in£ammation by an unknown mechanism. In the
present study, we have found that the K-melanocyte-stimulating
hormone (K-MSH) inhibited endotoxin-mediated nuclear tran-
scription factor UB (NF-UB) activation in di¡erent cells corre-
lated with the expression of K-MSH receptors. We have also
found for the ¢rst time that it induces cell death alone or in
endotoxin-stimulated mast cells. K-MSH-mediated apoptosis
was not observed in NF-UB overexpressed cells. The inhibitory
e¡ect of K-MSH was mediated through generation of cAMP, as
inhibitors of adenylate cyclase and of protein kinase A reversed
its inhibitory e¡ect. Overall, our results suggest that NF-UB is
the key molecule involved in K-MSH-mediated cell death and
this may help to regulate mast cell-mediated in£ammation.
- 2003 Published by Elsevier B.V. on behalf of the Federation
of European Biochemical Societies.
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1. Introduction
Mast cells play a central role in in£ammatory and immedi-
ate allergic reactions by virtue of their ability to release pre-
formed mediators, newly synthesized mediators, as well as
cytokines upon antigen activation thereby forming the genesis
of in£ammation [1]. As mast cells play a key role in in£am-
matory and immediate allergic reactions, the regulation of
mast cell activity becomes important. Mast cells reside imme-
diately beneath the thin epithelial lining of respiratory duct
and when exposed to allergens produce multi-mediators for
allergic responses. Mast cells are also found in the human
heart [2], and have been implicated in cardiovascular diseases
[3,4] as mast cell-derived mediators cause apoptosis of cardiac
myocytes and proliferation of non-myocytes [5] leading to
hypertrophied and failing hearts [6]. The transcription factors
thought to be involved in asthma are nuclear transcription
factor UB (NF-UB), AP-1, NF-AT, CREB, STATs, and
GATA-3. Most of the in£ammatory genes overexpressed in
asthma, such as those encoding proin£ammatory cytokines,
chemokines, adhesion molecules, and in£ammatory enzymes,
contain UB sites for NF-UB within their promoter, suggesting
that these genes are controlled predominantly by NF-UB [7].
Thus, regulation of NF-UB activation in mast cells appears to
be very important. NF-UB’s anti-apoptotic property has an
immense importance in regulating mast cells’ survival in aller-
gic responses. The size of any cell population represents a
balance between cell division and programmed cell death (ap-
optosis). In the case of mast cells, IL-3, IL-15, and stem cell
factor (SCF)-3 produced in extravascular tissues appear to
promote mast cell proliferation and maturation and prevent
apoptosis [8]. It is therefore important to elucidate the role of
NF-UB in these processes. Most of the in£ammatory genes are
overexpressed in asthma. NF-UB, a transcription factor, is
required for maximal transcription of many proin£ammatory
molecules which are overexpressed during asthma. Because
these molecules are regulated at the level of transcription
and are involved in the in£ammatory cascade, the regulation
of NF-UB is important to regulate asthma and other allergic
responses. NF-UB is an ideal target for apoptosis and the mast
cell death involving regulation of NF-UB may prove to be a
new strategy to regulate asthma.
Lipopolysaccharide (LPS), a glycolipid, is an integral com-
ponent of the outer membrane of Gram-negative bacteria.
LPS mediates a number of biological manifestations which
are believed to result from an uncontrolled production of
proin£ammatory cytokines such as TNF, IL-1, IL-6, IL-8,
IL-10, IL-12 etc. produced by cells. LPS interacts with most
cells through CD14, a 55 kDa glycophosphatidylinositol-an-
chored protein expressed on the surface of monocytes, macro-
phages, and neutrophils [9,10]. The binding of LPS to CD14 is
enhanced by the LPS binding protein (LBP) present in the
serum [10,11]. Mice lacking the CD14 gene show resistance
to LPS-induced shock [12]. In this study serum-activated LPS
(SA-LPS) was used to induce mast cells.
Neuropeptides have been implicated in the regulation of a
number of immune responses both in human and murine sys-
tems [13]. The K-melanocyte-stimulating hormone (K-MSH), a
tridecapeptide derived from pro-opiomelanocortin and found
in pituitary, brain, skin, and circulation [14] has been shown
to interact with various cells of the immune system and down-
regulate either the production or the action of the proin£am-
matory cytokines IL-1, TNF-K, and IL-6 [15^18], and thus
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acts as an anti-in£ammatory agent. Receptors for K-MSH
have been detected in di¡erent cell types [16,17]. At the mo-
lecular level, how K-MSH regulates in£ammation induced by
di¡erent stimuli is not understood. As NF-UB is involved both
in cell proliferation and in£ammation, the regulation of this
transcription factor will be helpful to regulate the mast cell
number, thereby mast cell-mediated in£ammation. In this
study, we are providing the data for the ¢rst time that
K-MSH induces cell death in mast cells, which may be of
immense importance to regulate mast cell-mediated in£amma-
tory and allergic responses in di¡erent mast cell-driven dis-
eases.
2. Materials and methods
2.1. Materials
LPS, K-MSH, 3-(4,5-dimethyl-2-thiozolyl)-2,5-diphenyl-2H-tetrazo-
lium bromide (MTT), and glycine were obtained from Sigma (St.
Louis, MO, USA). Penicillin, streptomycin, Dulbecco’s modi¢ed Ea-
gle’s medium (DMEM), WEHI-3 conditioned medium, and fetal
bovine serum (FBS) were obtained from Life Technologies (Grand
Island, NY, USA). Adenosine cyclic 3P,5P-phosphorothiolate tri-
ethylammonium salt (Rp-cAMPS) and H-8 [(methylamino)ethyl-5-iso-
quinolinesulfonamide, HCl] were obtained from Calbiochem (San
Diego, CA, USA). Dideoxyadenosine (ddAdo) and dibutyryl cAMP
were obtained from LC Laboratory (San Diego, CA, USA). Dihydro-
rhodamine was purchased from Molecular Probe, The Netherlands.
Antibodies (Abs) against p50, p65, and poly ADP-ribose polymerase
(PARP) were obtained from Santa Cruz Biotechnology (Santa Cruz,
CA, USA).
2.2. Cell lines
MC-9, HMC-1, Jurkat, H4, HuT-78, HeLa, U-937 cells, obtained
from American Type Culture Collection (Manassas, VA, USA) were
cultured according to their protocol. MC-9 cells were maintained in
DMEM supplemented with 0.5 WM 2-ME, 10% FBS, and 5% condi-
tioned medium (WEHI-3) containing IL-3 (30 ng/ml). Cells were my-
coplasma free, as tested by Gen-probe mycoplasma rapid detection kit
(Fisher Scienti¢c, Pittsburgh, PA, USA). To obtain bone marrow-
derived mast cells, 10-week-old mice bone marrow cells were har-
vested and cultured at a density of 106 cells/ml in DMEM supple-
mented with 100 Wg/ml penicillin/streptomycin, 0.1 WM 2-ME, 10%
FBS, and 10% WEHI-3 conditioned media containing IL-3. Culture
£asks were incubated in CO2 incubator. Half of the culture media was
replaced every 7 days. Mast cell purity was assessed after 7 weeks of
culture and about 95% cells were mast cells as assessed by metachro-
matic staining of cytopreparations with acidic toluidine blue, pH 1.0
[19].
2.3. Cytotoxicity assay
The cytotoxicity was measured by the MTT assay [20]. Brie£y,
MTT dye (100 Wg in 25 Wl PBS) was added to the treated cells (104
cells/well of a 96-well plate). After a 2 h incubation at 37‡C, 0.1 ml of
the extraction bu¡er (20% sodium dodecyl sulfate (SDS), 50% di-
methylformamide) was added. After 12 h incubation at 37‡C, the
absorbance was read at 570 nm.
2.4. NF-UB activation assay
NF-UB activation was assayed from nuclear extract (NE) using 4 ng
of 32P end-labeled 45-mer double-stranded NF-UB oligonucleotide
from the HIV-LTR, 5P-TTG TTA CAA GGG ACT TTC CGC
TGG GGA CTT TCC AGG GAG GCG TGG-3P by gel retardation
assay [21].
2.5. Transfection with p65 and dominant negative IUBK (IUBK-DN)
MC-9 and HuT-78 cells were transiently transfected by the calcium
phosphate method with 1 ml medium containing 0.5 Wg plasmid
DNAs for p65 and IUBK mutants (IUBK-DN) lacking either Ser32 or
Ser36 respectively with 0.5 Wg NF-UB promoter DNA linked to the
heat-stable secretory alkaline phosphatase (SEAP) gene [22]. The total
amount of DNA was maintained at 3 Wg by the addition of the
control plasmid pCMVFLAG1 DNA. After 12 h, cells were treated
with K-MSH for 24 h for cytotoxicity assay or NF-UB activity assay
by gel retardation. The culture-conditioned medium was used for
SEAP activity assay essentially as per the CLONTECH protocol
(Palo Alto, CA, USA).
2.6. Western blot of PARP
Cell death was examined by proteolytic cleavage of PARP [23].
Brie£y, cells were treated with K-MSH and whole cell extracts were
prepared. Cell extract protein (50 Wg) was analyzed for PARP by
Western blot analysis and detected by chemiluminescence (Amersham
Pharmacia Biotech, Piscataway, NJ, USA).
2.7. Determination of lipid peroxidation and measurement of reactive
oxygen intermediates (ROI)
Lipid peroxidation was determined by detection of thiobarbituric
acid-reactive malondialdehyde (MDA), an end product of the per-
oxidation of polyunsaturated fatty acids and related esters as de-
scribed [24,25]. The production of ROI was determined by £ow cyto-
metry using dihydrorhodamine 123 as £uorescent probe as described
[25].
2.8. Radiolabeling of K-MSH and receptor binding assay
K-MSH was iodinated with [125I]Na by the IODO-GEN method.
Radiolabeled ligand was puri¢ed by G25 sepharose column. The spe-
ci¢c activity of radiolabeled ligand was 0.5U107 cpm/Wg protein. Cell
surface receptors for K-MSH were detected following the method as
described previously [26]. The speci¢c binding was detected by sub-
tracting the counts obtained from 50-fold excess of unlabeled ligands
from labeled binding in the absence of unlabeled ligands (total).
3. Results
In this study, we examined the e¡ect of K-MSH on the
activation of transcription factor NF-UB. We used murine
mast cell line (MC-9) for these studies because these cells
express su⁄cient K-MSH receptors.
3.1. K-MSH inhibits SA-LPS-induced NF-UB activation
To detect the role of K-MSH on endotoxin-induced NF-UB
activation in murine mast cells (MC-9), cells were stimulated
with SA-LPS (100 ng of LPS was incubated with 20 Wl of
murine serum for 1 h at 37‡C and this mixture was SA-
LPS) for 1 h at 37‡C and then treated with di¡erent concen-
trations of K-MSH for 24 h at 37‡C. NE was prepared and
8 Wg NE proteins were analyzed in 6.6% native polyacrylamide
gel electrophoresis (PAGE) to detect NF-UB by gel shift assay.
The results shown in Fig. 1A indicate that K-MSH alone did
not activate NF-UB, but SA-LPS-induced NF-UB activation
was inhibited in a dose-dependent manner and at 104 pM
concentration of K-MSH completely abrogated SA-LPS-in-
duced NF-UB activation. From this results, it is clear that
K-MSH alone does not alter NF-UB activation but inhibits
SA-LPS-induced NF-UB activation. Various combinations of
Rel/NF-UB proteins can constitute an active NF-UB hetero-
dimer that binds to speci¢c sequences in DNA. To show that
the retarded band visualized by electrophoretic mobility shift
assay (EMSA) in SA-LPS-induced cells was indeed NF-UB,
we incubated the NEs from SA-LPS-activated cells with Abs
p50 (NF-UBI) and p65 (Rel A) or in combination and then
conducted EMSA. Abs to either subunit of NF-UB shifted the
band to a higher m.w. (Fig. 1B), thus suggesting that the SA-
LPS-activated complex consisted of p50 and p65 subunits.
MC-9 cells were exposed to SA-LPS for 1 h, then treated
with K-MSH for 0 to 36 h, and then NF-UB was assayed
from NE. SA-LPS-induced NF-UB activation was inhibited
maximally when the cells were treated for 24 h with K-MSH
(Fig. 1C).
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3.2. K-MSH inhibits SA-LPS-induced NF-UB reporter gene
activation
As SA-LPS-induced NF-UB activation was blocked by
K-MSH, the NF-UB-dependent gene expression also carried
out. MC-9 cells were transfected with NF-UB reporter plasmid
containing SEAP gene and/or IUBK-DN plasmid. Cells were
stimulated with SA-LPS for 4 h and replaced with fresh me-
dium. Cells were then treated with K-MSH for 24 h. Culture
supernatant was collected and used to assay SEAP activity.
The result in Fig. 1D indicated that SEAP activity was in-
duced with increased concentrations of SA-LPS. K-MSH (10
nM) completely inhibited SEAP activity at any concentrations
of SA-LPS. The IUBK-DN-transfected cells showed the basal
activity of SEAP even by SA-LPS-mediated stimulation indi-
cating the speci¢city of the assay.
3.3. K-MSH inhibits SA-LPS-induced ICAM-1 expression
As K-MSH inhibited SA-LPS-induced di¡erent biological
responses, the adhesion molecule ICAM-1, a NF-UB-depen-
dent gene product was detected in SA-LPS-stimulated MC-9
cells. Cells were stimulated with di¡erent concentrations of
SA-LPS for 12 h and then treated with K-MSH (10 nM) for
24 h. Then 100 Wg cell extract proteins were analyzed using
9% SDS^PAGE and ICAM-1 was detected by Western blot
analysis. SA-LPS-induced ICAM-1 expression was shown in a
dose-dependent manner but K-MSH-treated cells failed to in-
duce ICAM-1 expression by varying concentrations of SA-
LPS (Fig. 1E) suggesting K-MSH-mediated inhibition of SA-
LPS-induced ICAM-1 expression in mast cells.
3.4. Inhibition of NF-UB activation by K-MSH is cell-type
speci¢c
As NF-UB activation pathways di¡er in many cell types
Fig. 1. A: E¡ect of K-MSH on SA-LPS-induced NF-UB activation.
MC-9 cells (2U106/ml) were stimulated with SA-LPS (100 ng/ml)
for 2 h and then treated with di¡erent concentrations of K-MSH for
24 h at 37‡C, CO2 incubator. NF-UB was assayed from 8 Wg NE
proteins B: Supershift of NF-UB band. SA-LPS-induced NE was in-
cubated for 15 min with di¡erent Abs and then assayed for NF-UB.
C: Optimum time of K-MSH treatment to downregulate SA-LPS-in-
duced NF-UB activation. MC-9 cells, pretreated with or without
SA-LPS were treated with K-MSH (10 nM) for 0^36 h and then
NF-UB was assayed. D: E¡ect of K-MSH on SA-LPS-induced NF-
UB-dependent reporter gene expression. MC-9 cells were transiently
transfected with indicated plasmids along with NF-UB-containing
plasmid linked to the SEAP gene. The cells were cultured for 12 h
and then stimulated with di¡erent concentrations of SA-LPS for 4 h
as shown in the ¢gure. Cells were then treated with 10 nM K-MSH
for another 24 h. Culture supernatant was taken and assayed for
SEAP. E: E¡ect of K-MSH on SA-LPS-induced ICAM-1 induction.
Cells were stimulated with di¡erent concentrations of SA-LPS for
2 h and then treated with K-MSH (10 nM) for 24 h at 37‡C, CO2
incubator. ICAM-1 was detected from cell extract proteins (200 Wg)
by Western blot analysis. Tubulin was detected by reprobing the
same blot.
Fig. 2. A: E¡ect of K-MSH on SA-LPS-induced NF-UB activation
in di¡erent cell lines. Human glioma (H4), T-cell (Jurkat), and
mouse macrophage (Raw 264.7) cells were stimulated with SA-LPS
for 2 h and then incubated with 10 nM K-MSH for 24 h, 37‡C.
After these treatments, NEs were prepared and then assayed for
NF-UB. B: Levels of K-MSH receptors in di¡erent cells. U-937,
MC-9, and Jurkat (1U106) cells were taken in tubes as triplicate
sets. H4, HeLa, NIH 3T3, and Raw 264.7 cells were cultured in a
12-well plate as triplicate at 37‡C CO2 incubator. Cells were incuba-
ted with 4 ng iodinated K-MSH (5U104 cpm) per sample in pres-
ence or absence of 200 ng of unlabeled K-MSH for 2 h at 4‡C.
Then labeled K-MSH binding was assayed as described in Section 2.
C: Level of MC-1R in di¡erent cell lines. Di¡erent cells’ extract
(200 Wg) was analyzed in 9% SDS^PAGE and detected for MC-1R
using antiMC-1R antibody.
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[27^30], we therefore studied whether K-MSH a¡ects human
Jurkat (T) cells and H4 (glioma) cells and murine macrophage
(Raw 264.7) cells as well. It has been demonstrated that dis-
tinct signal transduction pathways could mediate induction in
epithelial, neuronal, and lymphoid cells. All the e¡ects of
K-MSH described above were conducted with MC-9 cells.
We found that K-MSH blocks SA-LPS-induced NF-UB acti-
vation in Jurkat cells completely, Raw 264.7 cells partially,
but not in H4 cells (Fig. 2A) suggest that this e¡ect of
K-MSH is restricted to T-cells but not glioma cells.
3.5. Levels of K-MSH receptors in di¡erent cells
To understand the speci¢city of K-MSH-mediated downre-
gulation of NF-UB, we detected the level of expression of
K-MSH receptors in di¡erent cells. H4, HeLa, and Raw
264.7 cells (1U106/well) were plated and incubated for over-
night in a 12-well plate. MC-9, U937, and Jurkat cells
(1U106/sample) were kept on ice in triplicate. Cells were in-
cubated with 4 ng 125I-labeled K-MSH (5U104 cpm) for 2 h at
4‡C in presence or absence of 50-fold cold K-MSH and
K-MSH binding was assayed. The results represented as
mean speci¢c binding in cpmRS.D. of triplicate samples
(Fig. 2B). The results indicate that the K-MSH receptors are
expressed in MC-9, Jurkat, and Raw 264.7 cells which re£ects
the K-MSH-mediated downregulation of SA-LPS-induced
NF-UB activation. K-MSH binds with its cell surface receptor
speci¢cally melanocortin-1 receptor (MC-1R). The levels of
MC-1R were detected using 200 Wg of di¡erent cells extract
proteins by Western blot analysis (Fig. 2C).
3.6. K-MSH induces cell death in MC-9 cells
To investigate the e¡ects of K-MSH on induction of cell
death in MC-9 cells di¡erent parameters (cell viability, thymi-
dine incorporation, lipid peroxidation, ROI generation, cas-
pase 8, and PARP cleavage) were assayed.
3.6.1. K-MSH induces cytotoxicity and inhibits 3H-thymi-
dine incorporation. To detect K-MSH-mediated cell viability,
MC-9 cells were stimulated with SA-LPS (100 ng/ml) for 2 h
and then treated with di¡erent concentrations of K-MSH for
36 h. Then cell viability was assayed by MTT assay and cell
proliferation was assayed by 3H-thymidine incorporation by
MC-9 cells. As shown in Fig. 3A, K-MSH induced cytotox-
icity in a dose-dependent manner in MC-9 cells. SA-LPS
stimulated cells showed about 20% increase in cell viability
than unstimulated cells. SA-LPS was unable to protect
K-MSH-mediated induction of cell death. Almost similar re-
sults showed for 3H-thymidine incorporation by K-MSH
treated cells (Fig. 3B). The results indicate that K-MSH alone
causes cell death in MC-9 cells and SA-LPS has no role to
protect K-MSH-mediated cell death. To show that the cell
death mediated by K-MSH was not due to necrosis, the cyto-
solic marker enzyme lactate dehydrogenase (LDH) was as-
sayed from the culture supernatant of K-MSH-treated cells
[31]. Culture supernatant from 1 WM of K-MSH-treated for
0, 12, 24, and 36 h when incubated with substrate solution
(0.23 M sodium pyruvate and 5 mM NADH in 0.1 M phos-
phate bu¡er, pH 7.5) did not decrease absorbance at 420 nm
(data not shown) indicating cell death was not due to leakage
of cytoplasm i.e. necrosis.
3.6.2. K-MSH induces lipid peroxidation in MC-9 cells. As
lipid peroxidation is a marker of cell death, we examined the
e¡ect of K-MSH on lipid peroxidation in MC-9 cells through
the detection of levels of MDA production. As shown in cell
viability, K-MSH-induced lipid peroxidation in a dose-depen-
dent manner and SA-LPS did not protect K-MSH-mediated
lipid peroxidation (Fig. 3C).
3.6.3. K-MSH induces ROI generation in MC-9 cells. ROI
generation is an intermediate step in cell death-induced by
di¡erent agents. To detect the role of K-MSH on SA-LPS-
induced ROI generation, MC-9 cells were stimulated with
SA-LPS for 2 h and then treated with di¡erent concentrations
of K-MSH for 24 h. Then ROI generation was examined with
dihydrorhodamine dye conversion to rhodamine as described
in Section 2. K-MSH-mediated ROI generation was shown
in a dose-dependent manner. SA-LPS-induced ROI genera-
tion was further increased with increased concentrations of
K-MSH indicating its additive e¡ect for ROI generation
(Fig. 3D).
3.6.4. K-MSH induces caspase 8 and PARP cleavage in
MC-9 cells. Cell death is re£ected in caspases activation,
Fig. 3. A,B: E¡ect of K-MSH on cell viability in SA-LPS-induced
MC-9 cells. MC-9 cells were stimulated with 100 ng/ml SA-LPS for
2 h and then 104 cells were taken in per well of a 96-well plate.
Cells were then treated with di¡erent concentrations of K-MSH for
36 h and cell viability was assayed by MTT uptake (A) or cells
were incubated with 0.5 WCi of 3H-thymidine (Tdr) for last 18 h
and then assayed for Tdr incorporation in the cells (B) as described
in Section 2. C,D: E¡ect of K-MSH on lipid peroxidation and ROI
generation in SA-LPS-induced MC-9 cells. Cell were stimulated with
SA-LPS for 2 h and then treated with di¡erent concentrations of
K-MSH for 24 h. Lipid peroxidation was assayed by measuring
MDA as represented in percentage above unstimulated cells (C).
ROI generation was assayed as the mean channel number by dihy-
drorhodamine in £ow cytometer (D). E,F: E¡ect of K-MSH on cas-
pase 8 and PARP cleavage in SA-LPS-stimulated cells. MC-9 cells
were stimulated with SA-LPS for 2 h and then treated with K-MSH
(10 nM) or TNF (1 nM) for 36 h. Then cell extract proteins were
assayed for caspase 8 (E) and PARP (F) by Western blot.
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which cleave a lot of proteins including PARP. Caspase 8
activation was shown by its auto-cleavage of precursor cas-
pase 8 into cleaved p20 caspase 8. K-MSH (10 nM) not only
induced the cleaved p20 caspase 8 alone but also SA-LPS pre-
stimulated cells as well (Fig. 3E). The level of precursor cas-
pase 8 was increased by K-MSH treatment. The same blot was
reprobed for tubulin protein and the intensity of bands in all
these lanes were equal suggesting loading control. K-MSH (10
nM) or TNF (1 nM) at 36 h induced PARP cleavage individ-
ually as detected by Western blot (Fig. 3F). In SA-LPS pre-
stimulated MC-9 cells, K-MSH induced PARP cleavage, indi-
cating that SA-LPS was unable to protect K-MSH-mediated
cell death.
3.7. K-MSH inhibits SA-LPS-induced NF-UB activation,
induces cell death and PARP cleavage in human mast cells
and mouse bone marrow-derived mast cells
As shown K-MSH-mediated inhibition of endotoxin-in-
duced NF-UB activation in murine mast cells (MC-9), this
e¡ect was also tested in human mast cell line, HMC-1 and
mouse bone marrow-derived mast, BM-mast, cells. Cells,
stimulated with autologus SA-LPS (100 ng/ml) for 2 h at
37‡C were treated with di¡erent concentrations of K-MSH
for 24 h at 37‡C and NF-UB was assayed from NEs. The
results indicated that K-MSH alone did not activate NF-UB,
but SA-LPS-induced NF-UB activation was inhibited in a
dose-dependent manner both in HMC-1 (Fig. 4A1) and
BM-mast (Fig. 4A2) cells. K-MSH alone induced cell death
in HMC-1 and BM-mast cells as detected by MTT assay and
SA-LPS was unable to protect K-MSH-mediated cell death
(Fig. 4B1,B2). However, K-MSH was unable to show the
same cell death in U-937, Jurkat, and another murine mast
cell line P815 (data not shown). K-MSH (10 nM) induced
PARP cleavage in a time-dependent manner both in HMC-1
and BM-mast cells (Fig. 4C) indicating the similar responses
of K-MSH in human mast cell line and mouse bone marrow-
derived mast cell as shown in MC-9 previously.
3.8. K-MSH inhibits NF-UB activation through cAMP
generation
It has been reported that K-MSH transduces its signal
through cAMP. To determine the role of cAMP, we used
ddAdo, a potent inhibitor of adenylate cyclase, enzyme re-
sponsible for the generation of cAMP [32]. Cells were exposed
to SA-LPS (100 ng/ml) for 2 h followed by ddAdo for 1 h and
then treated with K-MSH (106 pM) for 24 h. Then NF-UB
assayed from NEs. The results shown in Fig. 4D show that
ddAdo did not interfere with SA-LPS-induced NF-UB activa-
tion, but it protected against K-MSH-mediated suppression of
NF-UB stimulated by SA-LPS. Treatment of cells with exog-
enous cAMP (dibutyryl cAMP) inhibited SA-LPS-induced
NF-UB activation. (Fig. 4E). Since cAMP is known to activate
PKA, we also examined the e¡ects of two speci¢c PKA in-
hibitors, Rp-cAMPS isomer and H8 [33] and PKC inhibitor,
H7 on the K-MSH-induced inhibition of NF-UB activation.
For this, cells were stimulated with SA-LPS for 2 h followed
by treatment with either Rp-cAMPS isomer (100 WM), H-8
(2 WM), or H7 (10 nM) for 1 h at 37‡C and then treated with
K-MSH for 24 h. NF-UB was assayed from NE. Pretreatment
with both PKA inhibitors blocked the inhibitory e¡ects of
K-MSH, while PKC inhibitor H7 had no e¡ect on K-MSH-
mediated inhibition of NF-UB activation (Fig. 4E), suggesting
that the e¡ect of the PKA to inhibit K-MSH-mediated action
through generation of cAMP. As downregulation of NF-UB
re£ects the induction of cell death, the cAMP-mediated induc-
tion of cell death was observed in MC-9 cells and PKA in-
hibitors, Rp-cAMPS isomer or H-8, but not by PKC inhibitor
H7 protected K-MSH-mediated cell death as detected by MTT
assay (data not shown). These results suggest that K-MSH-
mediated cell death occurs through cAMP production fol-
lowed by downregulation of NF-UB in MC-9 cells.
3.9. Upregulated NF-UB protects K-MSH-mediated cell death
in MC-9 cells
In order to detect the role of NF-UB on K-MSH-mediated
cell death MC-9 cells were co-transfected with p65 plasmid
Fig. 4. A1,A2: E¡ect of K-MSH on SA-LPS-induced NF-UB activa-
tion in HMC-1 and bone marrow-derived primary mast cells.
HMC-1 (A1) and BM-mast cells (A2) were stimulated with SA-LPS
(100 ng/ml) for 2 h and then treated with di¡erent concentrations of
K-MSH for 24 h at 37‡C, CO2 incubator. NF-UB was assayed from
8 Wg NE proteins. B1,B2: E¡ect of K-MSH on cell viability in SA-
LPS-induced HMC-1 and BM-mast cells. Cells (104/well) were
stimulated with 100 ng/ml SA-LPS for 2 h and then treated with
di¡erent concentrations of K-MSH for 36 h and cell viability was
assayed by MTT uptake. C: E¡ect of K-MSH on PARP cleavage in
SA-LPS-stimulated HMC-1 and BM-mast cells. Cells were stimu-
lated with SA-LPS for 2 h and then treated with K-MSH (10 nM)
for 36 h. Then cell extract proteins were assayed for PARP by
Western blot. D: ddAdo protects from K-MSH-mediated inhibition
of NF-UB stimulated by SA-LPS. MC-9 cells (2U106/ml) were incu-
bated with SA-LPS for 2 h followed by ddAdo (250 WM) for 1 h
and then treated with K-MSH for 24 h. NF-UB was assayed from
NEs. E: The PKA inhibitor, cAMP-RP isomer and H8 protects
K-MSH-mediated inhibition of NF-UB induced by SA-LPS. MC-9
cells, stimulated with SA-LPS for 2 h, were treated with dibutyryl
cAMP (50 WM), Rp-cAMPS isomer (100 WM), H-8 (2 WM), or H7
(10 nM) for 1 h at 37‡C. Cells were then treated with K-MSH (10
nM) for 24 h. NEs were prepared and analyzed by EMSA.
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and SEAP reporter DNA. As shown in Fig. 5A1, p65-trans-
fected MC-9 cells showed NF-UB activation and K-MSH
treatment did not downregulate NF-UB. The SEAP activity
was observed in p65-transfected MC-9 cells about ¢ve-fold.
K-MSH did not downregulate the SEAP activity similar to
NF-UB activation (Fig. 5A2). Non-transfected and p65-trans-
fected cells were incubated with di¡erent concentrations of
K-MSH for 36 h and the cytotoxicity was assayed by MTT
uptake. The cell viability was decreased with increased con-
centrations of K-MSH in non-transfected MC-9 cells but p65-
transfected cells showed about 10% decrease of cell viability
(Fig. 5A3) indicating that NF-UB overexpressed cells are re-
sistant to K-MSH-mediated apoptosis.
3.10. Downregulation of NF-UB by IUBK-DN does not induce
cytotoxicity in HuT-78 cells
To con¢rm the role of NF-UB on K-MSH-mediated cell
death, HuT-78 cells (constitutively activated with NF-UB)
were transfected with IUBK-DN construct (mutation on
Ser32 and Ser36 position) and then these transfected and
non-transfected cells were treated with K-MSH for 24 h.
NF-UB was assayed from NEs. As shown in Fig. 5B1,
K-MSH-mediated downregulation of NF-UB (high activity of
basal level) was not observed. Fifty-fold cold oligo suppressed
the band indicating its speci¢city. In IUBK-DN-transfected
cells, no NF-UB activity was observed. The SEAP activity
from culture supernatant showed that the high basal level
(four-fold) was not decreased by K-MSH. IUBK-DN-trans-
fected cells did not show much SEAP activity (Fig. 5B2). In
order to detect the role of NF-UB on K-MSH-mediated cell
death, HuT-78 cells non-transfected and transfected with DN-
IUBK were treated with di¡erent concentrations of K-MSH for
24 h and then cell viability was assayed by MTT uptake.
HuT-78 cells showed 10^20% decrease in cell viability but
DN-IUBK-transfected cells showed cell death in a dose-depen-
dent manner by K-MSH (Fig. 5B3), indicating involvement of
NF-UB in K-MSH-mediated cell death.
4. Discussion
Even though several studies indicate that certain neuropep-
tides, such as K-MSH, have anti-in£ammatory e¡ects, the
mechanism underlying this e¡ect is not understood. Mast cells
are quick responder in allergic and in£ammatory diseases. As
in£ammatory responses are aggravated by NF-UB activation
followed by NF-UB-dependent gene activation, our strategy
was to regulate this transcription factor. Surprisingly, we ob-
served that K-MSH not only downregulates NF-UB in mast
cells, but also induces cell death. In this report we observed
that endotoxin induced NF-UB and NF-UB-dependent report-
er gene activation was inhibited by K-MSH (Fig. 1A,D,E).
K-MSH binds predominantly with its receptor MC-1R. The
level of K-MSH receptors as detected by radiolabeled K-MSH
binding (Fig. 2B) and Western blot (Fig. 2C) re£ects the
K-MSH-mediated NF-UB activation. The viable cell number
as detected by MTT dye uptake (Fig. 3A) and proliferating
cell number by thymidine incorporation (Fig. 3B) suggesting
that the cell death occurred due to K-MSH treatment. Lipid
peroxidation (Fig. 3C), ROI generation (Fig. 3D), precursor
caspase 8 cleavage (Fig. 3E), and caspase-dependent PARP
protein cleavage (Fig. 3F) all supported cell death. K-MSH-
mediated cell death was not due to necrosis as LDH, marker
for cytosol level was not observed in K-MSH-treated cells.
ROI has shown to induce NF-UB and activator protein-1
activation. In combination of K-MSH and SA-LPS showed
additive e¡ect on ROI generation, though SA-LPS (100 ng/
ml) alone induced about two-fold ROI generation than
K-MSH (1 WM). SA-LPS has been reported to maintain
NF-UB activation for a long time [20], which may be due to
ROI generated by it. However, an additional generation of
ROI by K-MSH may be detrimental to the cells, which needs
to be studied further. K-MSH-mediated biological activities
were observed not only in murine mast cell line but also in
human cell line and mouse bone marrow-derived primary
mast cells. However, why K-MSH did not show cell death
in another murine mast cell line or human lymphoid cells is
not understood. The reports so far available were that K-MSH
downregulates TNF-induced NF-UB activation through gen-
eration of cAMP and activation of PKA [34]. How generated
cAMP inhibits NF-UB activation was also investigated. It was
Fig. 5. A: Overexpressed NF-UB protects K-MSH-mediated inhibi-
tion of NF-UB and apoptosis in MC-9 cells. MC-9 cells were trans-
fected with p65 linked with SEAP construct, cultured for 12 h, and
then treated with K-MSH for 24 h. The NF-UB assayed from NEs
using 50-fold cold oligo for speci¢city (A1) and SEAP assayed from
cultured conditioned medium (A2). Transfected and non-transfected
MC-9 cells were treated with di¡erent concentrations of K-MSH
and assayed for cytotoxicity by MTT uptake (A3). B: E¡ect
K-MSH on HuT-78 cells transfected with IUBK-DN construct. HuT-
78 cells were transfected with IUBK-DN construct and culture for
12 h. Then cells were treated with K-MSH for 24 h. NF-UB was as-
sayed from NEs (B1) and SEAP assayed from cultured conditioned
medium (B2). Non-transfected and IUBK-DN-transfected HuT-78
cells were treated with di¡erent concentrations of K-MSH for 36 h
and cell viability was assayed (B3). The results represent the mean
absorbanceRS.D. of triplicate samples.
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also shown that the catalytic subunit of PKA (PKAc) asso-
ciates with IUBK, the inhibitory subunit of NF-UB in the cy-
toplasm [35]. Upon NF-UB activation by SA-LPS stimulation
a lot of genes including IUBK may be upregulated. This IUBK
possibly binds with PKAc forming PKAc-IUBK-p65 (NF-UB)
complex thereby downregulating NF-UB. How cAMP down-
regulates NF-UB is interesting though the previous report con-
¢rms this e¡ect and ddAdo, adenylate cyclase inhibitor re-
verses the function [34]. cAMP induces transcription factors
like AP-1 and CREB, but not NF-UB [36]. NF-UB may be
negatively downregulated by CREB. H7, an inhibitor of PKC,
had no e¡ect on the suppressive e¡ect of K-MSH, indicating
speci¢city.
Downregulation of NF-UB re£ects on cell death as shown
in K-MSH-treated cells. In unstimulated or SA-LPS-stimu-
lated mast cells K-MSH induced cell death as shown by di¡er-
ent assays. Surprisingly, K-MSH did not downregulate NF-UB
in mast cells, overexpressed with p65 (NF-UB) or HuT-78,
constitutively activated with NF-UB and showed 10^20% in-
duction of cell death (Fig. 5). Mechanism of endotoxin-medi-
ated NF-UB activation may be di¡erent than constitutively
expressed NF-UB in HuT-78 cells or overexpressed with p65
(NF-UB) in MC-9 cells. From these results it is clear that
K-MSH-mediated induction of cell death in mast cells depends
on NF-UB.
The anti-in£ammatory response of K-MSH is mediated by
downregulation of key in£ammatory molecule, NF-UB. The
cells with overexpressed NF-UB show anti-apoptotic response
[20]. In this report, we showed endotoxin induced NF-UB in
mast cell MC-9 and then tested the downregulation of NF-UB
by K-MSH through the production of cAMP. This downreg-
ulation of NF-UB re£ected on cell death. As mast cells are key
responder of allergic and in£ammatory responses in asthma,
gout arthritis, rheumatoid arthritis etc. and basal activation of
NF-UB has been shown in these diseases, so induction of cell
death by K-MSH in mast cells by downregulating NF-UB will
be helpful to regulate cell number in these diseases.
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